These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 811779

  • 21. Chemistry and function of the complement system.
    Müller-Eberhard HJ.
    Hosp Pract; 1977 Aug; 12(8):33-43. PubMed ID: 892784
    [No Abstract] [Full Text] [Related]

  • 22. Activation of therminal components of human complement by a trypsin-activated complex of human factor B and cobra venom factor.
    Miyama A, Kato T, Minoda I, Ueda T, Kashiba S.
    Jpn J Microbiol; 1976 Dec; 20(6):507-16. PubMed ID: 1035353
    [Abstract] [Full Text] [Related]

  • 23. Formation of EAC142 and EAC1423 with macrophage culture supernatant containing the secreted complement components C1 to C3.
    Brade V, Beuscher HU.
    Immunobiology; 1984 Mar; 166(2):177-89. PubMed ID: 6724636
    [Abstract] [Full Text] [Related]

  • 24. The functional significance of complement.
    Fearon DT, Ruddy S, Knostman JD, Carpenter CB, Austen KF.
    Adv Nephrol Necker Hosp; 1974 Mar; 4():15-35. PubMed ID: 4219991
    [No Abstract] [Full Text] [Related]

  • 25. Complement receptors and cell associated complement components.
    McConnell I, Lachmann PJ.
    Immunol Commun; 1977 Mar; 6(2):111-32. PubMed ID: 324894
    [Abstract] [Full Text] [Related]

  • 26. The reactivity of the complement system.
    Hadding U.
    Monogr Allergy; 1977 Mar; 12():36-45. PubMed ID: 335218
    [No Abstract] [Full Text] [Related]

  • 27. Complement activation in acute glomerulonephritis in children.
    Levy M, Sich M, Pirotzky E, Habib R.
    Ric Clin Lab; 1980 Mar; 10(1):87-91. PubMed ID: 7008160
    [No Abstract] [Full Text] [Related]

  • 28. Complement.
    Müller-Eberhard HJ.
    Annu Rev Biochem; 1975 Mar; 44():697-724. PubMed ID: 1094920
    [No Abstract] [Full Text] [Related]

  • 29. [Alternate complement pathway in Behçet disease (author's transl)].
    Kogure M, Ono Y.
    Nippon Ganka Gakkai Zasshi; 1975 Mar 10; 79(3):172-6. PubMed ID: 1171606
    [No Abstract] [Full Text] [Related]

  • 30. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ, Ramsey J, Hammer CH, Frank MM.
    J Immunol; 1983 Jul 10; 131(1):403-8. PubMed ID: 6602833
    [Abstract] [Full Text] [Related]

  • 31. Release of chemical mediators from both allergic and non-allergic human leukocytes.
    Grant JA, Dupree E, GoldmanAS.
    Int Arch Allergy Appl Immunol; 1975 Jul 10; 49(1-2):111-4. PubMed ID: 49308
    [No Abstract] [Full Text] [Related]

  • 32. Characteristics of complement consumption by atopic allergens.
    Berrens L, Van Rijswijk-Verbeek J, Guikers CL.
    Immunochemistry; 1976 May 10; 13(5):367-72. PubMed ID: 939579
    [No Abstract] [Full Text] [Related]

  • 33. A new activity of complement component C3: cell-bound C3b potentiates lysis of erythrocytes by C5b,6 and terminal components.
    Hammer CH, Abramovitz AS, Mayer MM.
    J Immunol; 1976 Sep 10; 117(3):830-4. PubMed ID: 956655
    [Abstract] [Full Text] [Related]

  • 34. The alternative pathway of complement activation.
    Götze O, Müller-Eberhard HJ.
    Adv Immunol; 1976 Sep 10; 24():1-35. PubMed ID: 798473
    [No Abstract] [Full Text] [Related]

  • 35. EAC4 and EAC14 production without purified Ci.
    Linscott WD.
    J Immunol; 1975 Dec 10; 115(6):1625-30. PubMed ID: 241767
    [Abstract] [Full Text] [Related]

  • 36. Activation of the complement and properdin systems in rheumatoid arthritis.
    Ruddy S, Austen KF.
    Ann N Y Acad Sci; 1975 Jun 13; 256():96-104. PubMed ID: 1099964
    [Abstract] [Full Text] [Related]

  • 37. Complement function and disorders.
    Kehoe JM.
    Pediatr Ann; 1976 Jun 13; 5(6):397-404. PubMed ID: 1272620
    [No Abstract] [Full Text] [Related]

  • 38. Circadian and circannual aspects of the complement cascade - new and old results, differing in specificity.
    Kim Y, Pallansch M, Carandente F, Reissmann G, Halberg E, Halberg F, Halberg F.
    Chronobiologia; 1980 Jun 13; 7(2):189-204. PubMed ID: 7428510
    [Abstract] [Full Text] [Related]

  • 39. C3 requirements for formation of alternative pathway C5 convertase.
    Daha MR, Fearon DT, Austen KF.
    J Immunol; 1976 Aug 13; 117(2):630-4. PubMed ID: 950465
    [Abstract] [Full Text] [Related]

  • 40. Complement and the clinician.
    Palmer DG.
    Aust N Z J Med; 1976 Aug 13; 6(4):349-56. PubMed ID: 1070993
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.